IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 121 filers reported holding IVERIC BIO INC in Q2 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $100,014,043 | +747.9% | 2,542,299 | +424.4% | 0.52% | +698.5% |
Q1 2023 | $11,795,160 | -62.3% | 484,799 | -66.8% | 0.06% | -65.2% |
Q4 2022 | $31,301,420 | +32.5% | 1,462,000 | +11.0% | 0.19% | +42.7% |
Q3 2022 | $23,627,000 | +353.1% | 1,317,000 | +74.5% | 0.13% | +322.6% |
Q4 2020 | $5,215,000 | +22.5% | 754,740 | 0.0% | 0.03% | +6.9% |
Q3 2020 | $4,257,000 | +11.3% | 754,740 | +0.6% | 0.03% | -6.5% |
Q2 2020 | $3,825,000 | – | 750,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |